Although clinical overlap between SLE and AGS has been reported in some patients, it remains unclear why some patients with TREX1 mutations develop a phenotype dominated by neuroinflammation and others do not (5, 51–53). The gene discussed is TREX1; the disease is Aicardi-Goutieres syndrome.